Wyeth chairman Robert Essner to retire

Share this article:
Robert Essner to retire
Robert Essner to retire

Wyeth has announced that Robert Essner will retire as chairman, effective June 27th, 2008.  Bernard Poussot, Wyeth's president and CEO will take over as chairman upon Essner's departure.

“Bob successfully led Wyeth's transformation from a holding company to what is now a world leader in pharmaceuticals that has grown in annual revenue from $14 billion in 2001 to more than $22 billion in 2007,” said Poussot in a statement.

Essner's exit from the chairman position, held since January 2003, completes the succession process which began in April 2006, when Poussot was promoted to president and vice chairman.  Poussot replaced Essner as Wyeth's CEO in January 2007.

Essner has worked at Wyeth since 1989, and was promoted to CEO in May 2001.

Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...